Ovid Therapeutics Inc.

Ovid Therapeutics Inc. - Current Ratioverified

OVID

Price:

$2.27

Market Cap:

$299.38M

Ovid Therapeutics Inc. is a biopharmaceutical firm dedicated to creating significant treatments for individuals and families impacted by neurological disorders across the United States. The company's robust pipeline features several key therapeutic candidates: OV101, a drug candidate currently undergoing Phase 2A clinical trials for Fragile X syndrome; OV329, an inhibitor targeting GABA aminotransferase, aimed at managing seizures linked to tuberous sclerosis complex and infantile spasms; and OV350, a small molecule developed to address various forms of epilepsy. Beyond these, Ovid is also advancing OV882, a short hairpin RNA (shRNA) gene therapy designed to treat Angelman syndrome, and OV81...[Read more]

Industry

Biotechnology

IPO Date

2017-05-05

Stock Exchange

NASDAQ

Ticker

OVID

The Current Ratio as of June 2026 (TTM) for Ovid Therapeutics Inc. (OVID) is 10.17

According to Ovid Therapeutics Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 10.17. This represents a change of 35.41% compared to the average of 7.51 of the last 4 quarters.

Ovid Therapeutics Inc. (OVID) Historical Current Ratio (quarterly & annually)

How has OVID Current Ratio performed in the past?

The mean historical Current Ratio of Ovid Therapeutics Inc. over the last ten years is 10.22. The current 10.17 Current Ratio has changed 9.85% with respect to the historical average. Over the past ten years (40 quarters), OVID's Current Ratio was at its highest in in the September 2016 quarter at 21.76. The Current Ratio was at its lowest in in the June 2016 quarter at 0.

Quarterly (TTM)
Annual

Average

10.22

Median

10.23

Minimum

3.39

Maximum

18.79

Ovid Therapeutics Inc. (OVID) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Ovid Therapeutics Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 279.44%

Maximum Annual Current Ratio = 18.79

Minimum Annual Increase = -65.98%

Minimum Annual Current Ratio = 3.39

Quarterly (TTM)
Annual
YearCurrent RatioChange
202510.91105.27%
20245.32-44.35%
20239.55-49.16%
202218.7945.99%
202112.87279.44%
20203.39-55.23%
20197.5851.38%
20185.01-65.98%
201714.714.80%
201614.04-53.88%

Ovid Therapeutics Inc. (OVID) Average Current Ratio

How has OVID Current Ratio performed in the past?

The current Current Ratio of Ovid Therapeutics Inc. (OVID) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

8.59

5-year avg

11.49

10-year avg

10.22

Ovid Therapeutics Inc. (OVID) Current Ratio vs. Peers

How is OVID’s Current Ratio compared to its peers?

Ovid Therapeutics Inc.’s Current Ratio is greater than Context Therapeutics Inc. (8.96), greater than MacroGenics, Inc. (1.90), greater than Clene Inc. (1.94), greater than Oramed Pharmaceuticals Inc. (6.45), less than Shattuck Labs, Inc. (22.06), less than ImageneBio Inc (18.39), greater than Connect Biopharma Holdings Limited (3.74), greater than InflaRx N.V. (4.16), less than Whitehawk Therapeutics Inc (11.36), less than Kalaris Therapeutics Inc (12.14),

Build a custom stock screener for Ovid Therapeutics Inc. (OVID) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Ovid Therapeutics Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Ovid Therapeutics Inc. (OVID) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Ovid Therapeutics Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Current Ratio?

How can you use the Current Ratio?

What is Ovid Therapeutics Inc.'s Current Ratio?

How is the Current Ratio calculated for Ovid Therapeutics Inc. (OVID)?

What is the highest Current Ratio for Ovid Therapeutics Inc. (OVID)?

What is the 3-year average Current Ratio for Ovid Therapeutics Inc. (OVID)?

What is the 5-year average Current Ratio for Ovid Therapeutics Inc. (OVID)?

How does the current Current Ratio for Ovid Therapeutics Inc. (OVID) compare to its historical average?